197

Drug Discovery
Sub Categories on Drug Discovery
Latest Articles
Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum
Medicine Net Update 2025/07/10

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Medicine Net Update 2025/07/10

On Jul 03, 2025, Norvatis announced results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).